Join P95 Julius Clinical at OCT New England in Boston from October 27-28, 2026.

Visit our team at booth #58 to learn how P95 Julius Clinical supports biotech and pharmaceutical sponsors through complex clinical development programs. Our team brings deep therapeutic and scientific expertise to help advance innovative therapies from early-phase development through late-phase clinical research. We partner with sponsors to design and execute high-quality studies that address critical scientific, regulatory, and patient-centered questions.

Let’s Meet in Boston!

Connect with our team at the event to discuss how we can support your next clinical trial.

Name(Required)

Advancing Clinical Development and Evidence Generation Through Science and Partnership

P95 Julius Clinical is a global, science-led contract research organization (CRO) supporting clinical development from early-phase trials through late-phase and real-world evidence programs. The company specializes in complex research for biotech and pharmaceutical sponsors, with deep expertise across neuroscience, infectious diseases and vaccines, and cardiovascular, renal, and metabolic diseases. Backed by a leadership of scientific luminaries and more than 500 experts spanning five continents, P95 Julius Clinical combines the reach of a larger CRO with the agility of a mid-sized partner.

Learn more about our therapeutic expertise.